Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
August 06, 2025
Experience Agility-driven clinical trials with CBCC!
Experience Agility-driven clinical trials with CBCC!
Our methodologies prioritize speed, delivering high-quality research outcomes.
Therapeutic Focus:
· Oncology
· Ophthalmology
· Neuro-Psychiatry
· Rare Diseases
CBCC simplifies complex clinical research - delivering fast, accurate, and effective solutions across diverse therapeutic areas.
To book a discovery call and know more, please write to us at: bd@cbcc.global
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION
Manoj Vyas Dr. Sandeep Singh Jaimeen Vanparia Sanjeev Ganatra Nikhil Gandhi Harakh Shah, PMP® Tapan Shah Kinnari Gandhi RQAP-GCP Dr Praveen Choudhary Nikunj Patel Ankit Parikh Ajit Upadhyaya Ankit Pandav Devang Pandya Jay Vyas Udayan Vyas
ClinicalResearch PharmaceuticalScience DrugDevelopment
ClinicalTrials PhaseITrial MedicalResearch
